2007, Biopharma and Food and Drug Administration

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Biopharma

Food and Drug Administration

Innovations & Challenges in Brain Health

PM360

NOVEMBER 12, 2024

They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. Not surprisingly, several companies have been in and out of brain health diseases.

Food and Drug Administration

Food and Drug Administration Healthcare Provider Healthcare Healthcare

First continuous mRNA manufacturing platform to be developed

European Pharmaceutical Review

JULY 17, 2023

The $82 million project is funded by the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research. This $85 million programme ran between 2007 and 2019. Continuous manufacturing should also improve the quality of mRNA production through automation and in-line analytics, Braatz noted.

Manufacturing

Manufacturing Food and Drug Administration Engineering Biopharma

Pharma Rep Focus

Innovations & Challenges in Brain Health

First continuous mRNA manufacturing platform to be developed

Stay Connected